GR073610MA/Wellcome Trust/United Kingdom[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2007	1
2008	1
2011	1
2016	1
2025	0

Page 1

MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients.

Mouton JM, van der Merwe L, Goosen A, Revera M, Brink PA, Moolman-Smook JC, Kinnear C. Mouton JM, et al. Hum Genet. 2016 May;135(5):477-483. doi: 10.1007/s00439-016-1649-7. Epub 2016 Mar 11. Hum Genet. 2016. PMID: 26969327

Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.

Revera M, van der Merwe L, Heradien M, Goosen A, Corfield VA, Brink PA, Moolman-Smook JC. Revera M, et al. Cardiovasc Res. 2008 Mar 1;77(4):687-94. doi: 10.1093/cvr/cvm075. Epub 2007 Nov 20. Cardiovasc Res. 2008. PMID: 18029407

Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C.

Uys GM, Ramburan A, Loos B, Kinnear CJ, Korkie LJ, Mouton J, Riedemann J, Moolman-Smook JC. Uys GM, et al. BMC Cell Biol. 2011 May 10;12:18. doi: 10.1186/1471-2121-12-18. BMC Cell Biol. 2011. PMID: 21569246 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year